SQOR-V: A Patient Reported Outcome Specifically Dedicated to Chronic Venous Disorders

  • J.-J. Guex
  • S. E. Zimmet
  • S. Boussetta
  • C. Taieb


Chronic venous disorders ( CVD) are recognized on a number of clinical signs of variable severity, from telangiectasias to skin ulceration of the lower legs. Their symptomatology is highly variable as well. Evaluation of the global severity of the disease remains difficult, except when considering late stages and complications, which represent only a vary small group of patients. No biological or instrumental marker exists which could be correlated to improvement or worsening whether spontaneous or after treatment. All these characteristics of CVD explain why Patient Reported Outcome ( PRO) are becoming a popular part of phlebological research.

The SQOR-V is a validated PRO designed for Chronic Venous Disorders (CVD). It allows a relevant and sensitive assessment of clinical features and quality of life of patients at all stages of Chronic Venous Disorders (CVD). It can be used in epidemiological and clinical trials. It is sensitive enough to assess CVD at early stages of the disease.

Using the SQOR-V in clinical trials is possible for any kind of treatment for CVD: drugs, compression, surgery, or endovenous ablation. It adds a composite global assessment complementary to hemodynamic measurements.

The SQOR-V can be used freely; provided it is applied according to its construction rules and that its authors are informed of the intended use. More studies are needed to validate versions in more languages and to better refine its practical use.


Patient Reported Outcome Varicose Vein Chronic Venous Insufficiency Chronic Venous Insufficiency Hemodynamic Abnormality 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

List of Abbreviations:


chronic venous disorders


quality of life


patient reported outcome


  1. Eklöf B. (2006). Classifying venous disease In: Bergan JJ (ed.) The Vein Book. Elsevier, San Diego.Google Scholar
  2. Fuhrer R, Rouillon F. (1989). Psychiatrie et Psychobiologie. 4:163–166.Google Scholar
  3. Guex JJ, Myon E, Didier L, Nguyen Le C, Taieb C. (2005). Int Angiol. 24: 258–264.PubMedGoogle Scholar
  4. Guex JJ, Zimmet SE, Boussetta S, Nguyen Le C, Taieb C. (2007). J Mal Vasc. 32: 135–147.PubMedGoogle Scholar
  5. Haibel H, Niewerth M, Brandt J, Rudwaleit M, Listing J, Sieper J, et al. (2004). Z Rheumatol. 63(5): 393–401.PubMedCrossRefGoogle Scholar
  6. Kahn S, Lamping D, Ducruet T, Arsenault L, Miron M, Roussin A, et al. (2006). J Clin Epidemiol. 59: 1049–1056.PubMedGoogle Scholar
  7. Launois R, Reboul-Marty J, Henry B. (1996). Qual Life Res. 5(6): 539–554.PubMedCrossRefGoogle Scholar
  8. Miletin MS, Hanly PJ. (2003). Sleep Med. 4(3):195–199.PubMedCrossRefGoogle Scholar
  9. Porter JP, Moneta GM. (1995). J Vasc Surg. 21:635–645.PubMedCrossRefGoogle Scholar
  10. Smith JJ, Garratt AM, Guest M, Greenhalgh RM, Davies AH. (1999). J Vasc Surg. 30(4): 710–719.PubMedCrossRefGoogle Scholar
  11. Ware JE Jr, Kosinski M, Keller SD. (1996). Med Care. 34: 220–233.PubMedCrossRefGoogle Scholar
  12. Ware JE Jr, Sherbourne CD. (1992). Med Care. 30(6): 473–483.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media LLC 2010

Authors and Affiliations

  • J.-J. Guex
  • S. E. Zimmet
  • S. Boussetta
  • C. Taieb

There are no affiliations available

Personalised recommendations